MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.mayocp.2025.07.024

Медицинская библиотека · Mayo Clinic proceedings · 2025

External Validation of the Mayo Delirium Prediction Tool in Individuals With Cancer.

Ali Noman, Magnabosco Lara, Soones Tacara, Chopra Deepti, Gaeta Maria Susan, Lin Heather, Ayanian Shant, Pagali Sandeep, Halm Josiah

СтатьяВалидационное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

To validate the Mayo Delirium Prediction (MDP) tool in a population of patients with cancer.

METHODS

This institutional review board-approved, retrospective validation study included 930 hospitalized cancer patients, aged 50 years or older, admitted to the University of Texas MD Anderson Cancer Center from September 1, 2022, to September 1, 2023. Patients with acute substance use disorder were excluded. Recalibrated MDP variables recorded within 24 hours of admission were extracted from the electronic health record. The MDP tool's predictive accuracy was assessed by receiver operating characteristic curves, sensitivity, specificity, positive predictive value, and negative predictive value for patients admitted to medical and surgical services.

RESULTS

The cohort comprised 767 medical and 163 surgical patients (median age, 67 years). The MDP tool demonstrated areas under the receiver operating characteristic curve of 0.8047 (95% CI, 0.7585 to 0.8509) for the entire cohort, 0.7867 (95% CI, 0.7371 to 0.8363) for medical patients, and 0.9488 (95% CI, 0.8795 to 1.0000) for surgical patients. At a high risk for delirium score of 0.3 or above, sensitivity was 42.6% (95% CI, 32.6% to 52.5%) and specificity was 94.6% (95% CI, 93.1% to 96.1%). At a low risk for delirium score of 0.05 or lower, sensitivity was 88.3% (95% CI, 81.8% to 94.8%) but specificity was 50.5% (95% CI, 47.1% to 53.9%).

CONCLUSION

The MDP tool demonstrates good capability for predicting delirium risk in hospitalized cancer patients. Prediction was even more robust in surgical patients compared with medical patients. Performance differs by predictive risk, highlighting the need for tailored risk cutoff application in clinical practice.

Для цитирования: Ali Noman, Magnabosco Lara, Soones Tacara, Chopra Deepti, Gaeta Maria Susan, Lin Heather, Ayanian Shant, Pagali Sandeep, Halm Josiah. External Validation of the Mayo Delirium Prediction Tool in Individuals With Cancer.. Mayo Clinic proceedings. 2025. DOI: 10.1016/j.mayocp.2025.07.024.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.